Javascript must be enabled to continue!
A rare case of autoimmune hemolytic anemia secondary to HCV/HIV coinfection complicated with chronic kidney disease
View through CrossRef
Abstract
Background:
Autoimmune hemolytic anemia (AIHA) is an acquired disorder characterized by destruction of RBCs auto-antibodies, leading to varying degrees of anemia, from mild to life-threatening. Human immunodeficiency virus (HIV) can trigger autoimmunity complications including Autoimmune hemolytic anemia through various molecular mechanisms. Moreover AIHA is considered a rare extrahepatic manifestation of hepatitis-C virus. HCV/HIV coinfection increases the risk of AIHA incidence
Case report:
A 42-year-old male patient with a history of IV drug abuse and chronic HCV/HIV coinfection referred to the emergency center with complaints of lethargy, fatigue and shortness of breath. The patient’s past medical history revealed that he was nondiabetic and non-hypertensive and nonalcoholic. In the physical examination, icteric sclera and mild splenomegaly were evident. Considering the severe anemia (Hgb: 3.9 mg/dl), hyperbilirubinemia (Total/direct bilirubin: 2.5/0.6 mg/dl), elevated LDH, splenomegaly, positive HCV and HIV serological tests and positive coombs test, diagnosis of AIHA secondary to HIV/HCV was entertained.
Discussion:
We presented a rare case of AIHA secondary to HCV/HIV co-infection with concurrent acute severe hepatitis and ESRD. The exact cause of increased CKD risk in HCV-HIV co-infected individuals remains unclear. Chronic HCV infection is associated with increased deterioration of renal function and incidence of ESRD and CKD. A wide range of kidney diseases might occur in HIV positive Patients and HCV/HIV coinfection is associated with aggravation of renal failure. CKD risk is higher in HCV co-infected patients compared to those with HIV mono-infection.
Conclusion:
AIHA is rare cause of anemia and a potentially life-threatening phenomena in HCV/HIV infected individuals. A high degree of clinical suspicion for AIHA diagnosis in patients with HCV/HIV coinfected is crucial for proper management. Moreover HCV/HIV coinfection is associated with progression to CKD.
Title: A rare case of autoimmune hemolytic anemia secondary to HCV/HIV coinfection complicated with chronic kidney disease
Description:
Abstract
Background:
Autoimmune hemolytic anemia (AIHA) is an acquired disorder characterized by destruction of RBCs auto-antibodies, leading to varying degrees of anemia, from mild to life-threatening.
Human immunodeficiency virus (HIV) can trigger autoimmunity complications including Autoimmune hemolytic anemia through various molecular mechanisms.
Moreover AIHA is considered a rare extrahepatic manifestation of hepatitis-C virus.
HCV/HIV coinfection increases the risk of AIHA incidence
Case report:
A 42-year-old male patient with a history of IV drug abuse and chronic HCV/HIV coinfection referred to the emergency center with complaints of lethargy, fatigue and shortness of breath.
The patient’s past medical history revealed that he was nondiabetic and non-hypertensive and nonalcoholic.
In the physical examination, icteric sclera and mild splenomegaly were evident.
Considering the severe anemia (Hgb: 3.
9 mg/dl), hyperbilirubinemia (Total/direct bilirubin: 2.
5/0.
6 mg/dl), elevated LDH, splenomegaly, positive HCV and HIV serological tests and positive coombs test, diagnosis of AIHA secondary to HIV/HCV was entertained.
Discussion:
We presented a rare case of AIHA secondary to HCV/HIV co-infection with concurrent acute severe hepatitis and ESRD.
The exact cause of increased CKD risk in HCV-HIV co-infected individuals remains unclear.
Chronic HCV infection is associated with increased deterioration of renal function and incidence of ESRD and CKD.
A wide range of kidney diseases might occur in HIV positive Patients and HCV/HIV coinfection is associated with aggravation of renal failure.
CKD risk is higher in HCV co-infected patients compared to those with HIV mono-infection.
Conclusion:
AIHA is rare cause of anemia and a potentially life-threatening phenomena in HCV/HIV infected individuals.
A high degree of clinical suspicion for AIHA diagnosis in patients with HCV/HIV coinfected is crucial for proper management.
Moreover HCV/HIV coinfection is associated with progression to CKD.
Related Results
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract
Introduction
Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
T cell responses from blood donors infected with different HCV genotypes against HCV 1a proteins
T cell responses from blood donors infected with different HCV genotypes against HCV 1a proteins
Hepatitis C virus (HCV) infection, which can cause chronic liver diseases, cirrhosis and hepatocellular carcinoma, is still a major public health problem worldwide. Upon comparing ...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
INFLUENCE OF HOST AND VIRAL FACTORS IN HEPATITIS C VIRUS INFECTION: ROLE OF TA REPEAT, IFNL3 AND IFNL4 POLYMORPHISMS IN HCV INFECTION AND OUTCOME OF TREATMENT
INFLUENCE OF HOST AND VIRAL FACTORS IN HEPATITIS C VIRUS INFECTION: ROLE OF TA REPEAT, IFNL3 AND IFNL4 POLYMORPHISMS IN HCV INFECTION AND OUTCOME OF TREATMENT
Hepatitis C virus (HCV) is a serious public health problem affecting 170 million carriers worldwide. It is a leading cause of chronic hepatitis, cirrhosis, and liver cancer and is ...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
Systemic inflammation, endothelial dysfunction and coagulopathy are of high clinical relevance in the management of people living with HIV (PLWH), and even more in patients coinfec...

